UBS O'Connor’s Vicarious Surgical RBOT Stock Holding History

UBS O'Connor’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18,661	Closed	-$610K	–	902
2020 Q4	$610K	Buy	+18,661	New	+$5.48M	0.01%	470

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS O'Connor's RBOT Position: Q3 2021 in Review

UBS O'Connor sold out of Vicarious Surgical (RBOT) in Q3 2021, closing a stake of 2,417 shares — an estimated $723K sold.

UBS O'Connor first reported a position in RBOT in Q4 2020 and held it in 3 quarters. The position peaked at $8.81M in Q4 2020. 35 funds tracked by Wall St. Rank hold RBOT as of Q3 2021.

UBS O'Connor reported no remaining Vicarious Surgical position as of Q3 2021 after selling out during the quarter.
UBS O'Connor sold 2,417 Vicarious Surgical shares in Q3 2021, an estimated $723K.
UBS O'Connor first reported a position in Vicarious Surgical in Q4 2020 and held it in 3 quarters.
UBS O'Connor's Vicarious Surgical position peaked at $8.81M in Q4 2020.
35 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2021.

Based on UBS O'Connor's 13F filing for Q3 2021, filed 12 Nov 2021.